A
Active Biotech AB publ
F:BTPC
Active Biotech AB publ
F:BTPC
Price:
0.497
EUR
-1.97%
Market Closed
Market Cap:
€188.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Active Biotech AB publ
F:BTPC
|
SE |
|
T
|
Takeda Pharmaceutical Co Ltd
DUS:TKD
|
JP |
|
M
|
Mercer International Inc
F:AEZ
|
CA |
|
A
|
Archean Chemical Industries Ltd
NSE:ACI
|
IN |
|
C
|
Cerner Corp
F:CRE
|
US |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
XMUN:ME9
|
IT |
Wall St Price Targets
BTPC Price Targets Summary
Active Biotech AB publ
Active Biotech AB publ
Wall Street analysts forecast BTPC stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for BTPC is 2.382 EUR with a low forecast of 2.359 EUR and a high forecast of 2.452 EUR.
Lowest Forecast
Price Target
2.359
EUR
375% Upside
Average Forecast
Price Target
2.382
EUR
379% Upside
Highest Forecast
Price Target
2.452
EUR
393% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BTPC's stock price target?
Price Target
2.382
EUR
2.382
EUR
According to Wall Street analysts, the average 1-year price target for BTPC is 2.382 EUR with a low forecast of 2.359 EUR and a high forecast of 2.452 EUR.
